NCT04583787View on ClinicalTrials.gov

xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 7, 2021

Primary Completion Date

May 28, 2024

Study Completion Date

May 28, 2024

Conditions
Coronary Artery Disease
Interventions
DIAGNOSTIC_TEST

99mTc-sestamibi myocardial perfusion SPECT

82Rb-PET/CT with CT based coronary angiography (CCTA) as part of clinical care at Day 1

DIAGNOSTIC_TEST

82Rb-Chloride myocardial perfusion PET with CCTA

stress-rest 99mTc-sestamibi myocardial perfusion SPECT, performed subsequent to 99mTc-sestamibi myocardial perfusion SPECT at Day 2

Trial Locations (1)

4031

Clinic of Radiology & Nuclear Medicine, University Hospital of Basel, Basel

All Listed Sponsors
collaborator

Siemens Corporation, Corporate Technology

INDUSTRY

lead

University Hospital, Basel, Switzerland

OTHER

NCT04583787 - xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease | Biotech Hunter | Biotech Hunter